| Citation: |
ZHANG Jing, MAO Ying. Value of combined assessment of serum transforming growth factor-β1, interleukin-6, toll-like receptor-4, and nuclear factor-κb in evaluating the severity of radiation pneumonitis in non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(14): 12-17. DOI: 10.7619/jcmp.20234065
|
To explore the value of combined assessment of serum transforming growth factor-β1(TGF-β1), interleukin-6(IL-6), Toll-like receptor-4(TLR-4), and nuclear factor-κB (NF-κB) in evaluating the severity of radiation pneumonitis (RP) in non-small cell lung cancer (NSCLC) patients.
A total of 104 NSCLC patients with secondary RP after radiotherapy were selected as study group, and 52 NSCLC patients without secondary RP after radiotherapy were selected as control group.Serum levels of TGF-β1, IL-6, TLR-4, and NF-κB before and after radiotherapy were compared between the two groups.The levels of these serum markers in RP patients with different severity in the study group were also compared.The value of each serum marker alone and their combination for assessing the severity of RP after NSCLC radiotherapy was analyzed.
After radiotherapy, the serum levels of TGF-β1, IL-6, TLR-4, and NF-κB in the study group were significantly higher than those in the control group (P < 0.05).After radiotherapy, with the increase in the severity of RP, the serum levels of TGF-β1, IL-6, TLR-4, and NF-κB in the study group showed an increasing trend (P < 0.05).Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) for assessing grade 1 RP was 0.787 for TGF-β1, 0.718 for IL-6, 0.783 for TLR-4, and 0.801 for NF-κB, while the AUC for assessing ≥ grade 2 RP was 0.729, 0.740, 0.793, and 0.825, respectively.The risk of developing ≥ grade 2 RP in patients with positive expression of serum TGF-β1, IL-6, TLR-4, and NF-κB was 2.473, 2.275, 2.610, and 5.267 times higher than that in patients with negative expression, respectively (P < 0.05).The AUC for combined assessment of ≥ grade 2 RP using serum TGF-β1, IL-6, TLR-4, and NF-κB was 0.939, with a sensitivity of 76.00% and a specificity of 97.47%.
The serum levels of TGF-β1, IL-6, TLR-4, and NF-κB in NSCLC patients after radiotherapy are positively correlated with the severity of RP.The combined assessment of these four markers has significant value in evaluating ≥ grade 2 RP and can provide a reference for clinical control of RP.
| [1] |
THEELEN W S M E, CHEN D W, VERMA V, et al. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials[J]. Lancet Respir Med, 2021, 9(5): 467-475. doi: 10.1016/S2213-2600(20)30391-X
|
| [2] |
尹航. 驱动基因阳性非小细胞肺癌的免疫检查点抑制剂治疗的研究进展[J]. 实用临床医药杂志, 2023, 27(10): 144-148. doi: 10.7619/jcmp.20223698
|
| [3] |
PECHOUX C L, POUREL N, BARLESI F, et al. Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 involvement (Lung ART): an open-label, randomised, phase 3 trial[J]. Lancet Oncol, 2022, 23(1): 104-114. doi: 10.1016/S1470-2045(21)00606-9
|
| [4] |
孙晨楠, 毛海燕, 魏本飞, 等. 4D-CT联合呼吸门控技术应用于肺癌立体定向体部放疗的临床研究[J]. 实用临床医药杂志, 2022, 26(15): 15-18, 25. doi: 10.7619/jcmp.20220635
|
| [5] |
FUJIWARA M, DOIH, IGETA M, et al. Radiation pneumonitis after volumetric modulated arc therapy for non-small cell lung cancer[J]. Anticancer Res, 2021, 41(11): 5793-5802. doi: 10.21873/anticanres.15396
|
| [6] |
李锐彪, 任成波, 王聪, 等. 不同肺容积方法定义的剂量学参数预测放疗后非小细胞肺癌患者放射性肺炎的效能比较[J]. 实用临床医药杂志, 2022, 26(19): 5-8, 13. doi: 10.7619/jcmp.20221246
|
| [7] |
刘维鹏, 朱青山, 冯连杰, 等. 中性粒细胞与淋巴细胞比值、白细胞介素-17A及转化生长因子-β对局部晚期非小细胞肺癌患者发生放射性肺炎的诊断价值[J]. 癌症进展, 2022, 20(3): 282-285. https://www.cnki.com.cn/Article/CJFDTOTAL-AZJZ202203013.htm
|
| [8] |
ZHOU H L, LU Y T, WEI H, et al. Stat3/IL-6 signaling mediates sustained pneumonia induced by Agiostrongylus cantonensis[J]. PLoS Negl Trop Dis, 2022, 16(5): e0010461. doi: 10.1371/journal.pntd.0010461
|
| [9] |
ATWA A M, ABD EL-GHAFAR O A M, HASSANEIN E H M, et al. Candesartan attenuates cisplatin-induced lung injury by modulating oxidative stress, inflammation, and TLR-4/NF-κB, JAK1/STAT3, and Nrf2/HO-1 signaling[J]. Pharmaceuticals, 2022, 15(10): 1222. doi: 10.3390/ph15101222
|
| [10] |
中华医学会, 中华医学会肿瘤学分会, 中华医学会杂志社. 中华医学会肺癌临床诊疗指南(2018版)[J]. 中华肿瘤杂志, 2018, 40(12): 935-964. doi: 10.3760/cma.j.issn.0253-3766.2018.12.012
|
| [11] |
ARROYO-HERNÁNDEZ M, MALDONADO F, LOZANO-RUIZ F, et al. Radiation-induced lung injury: current evidence[J]. BMC Pulm Med, 2021, 21(1): 9. doi: 10.1186/s12890-020-01376-4
|
| [12] |
YING H J, FANG M, HANG Q Q, et al. Pirfenidone modulates macrophage polarization and ameliorates radiation-induced lung fibrosis by inhibiting the TGF-β1/Smad3 pathway[J]. J Cell Mol Med, 2021, 25(18): 8662-8675. doi: 10.1111/jcmm.16821
|
| [13] |
贺巧峰, 苏乐, 王英娟. 单核细胞趋化蛋白-1、基质金属蛋白酶-9、转化生长因子β1在哮喘急性发作患儿血清中的表达及意义[J]. 中国临床医生杂志, 2019, 47(5): 601-604. doi: 10.3969/j.issn.2095-8552.2019.05.033
|
| [14] |
姜朕, 钮明杨, 汪浩森, 等. 血清内皮细胞特异性分子-1、表面活性蛋白-D及转化生长因子-β1对脓毒症患儿继发急性肺损伤的预测价值[J]. 中国临床医生杂志, 2021, 49(6): 731-733. doi: 10.3969/j.issn.2095-8552.2021.06.032
|
| [15] |
丁丽丽, 刘轩绮, 孙晓林, 等. 系统性硬化症相关间质性肺病、特发性肺纤维化与转化生长因子-β诱导的肺纤维化模型重叠基因的相关性分析[J]. 实用临床医药杂志, 2022, 26(14): 7-13. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL202214002.htm
|
| [16] |
来志龙, 徐寒梅, 赵万洲, 等. 特发性肺纤维化相关信号通路及治疗药物研究进展[J]. 药学进展, 2022, 46(7): 535-544. https://www.cnki.com.cn/Article/CJFDTOTAL-YXJZ202207007.htm
|
| [17] |
WU S Y, CHEN Y T, TSAI G Y, et al. Protective effect of low-molecular-weight fucoidan on radiation-induced fibrosis through TGF-β1/smad pathway-mediated inhibition of collagen Ⅰ accumulation[J]. Mar Drugs, 2020, 18(3): 136. doi: 10.3390/md18030136
|
| [18] |
TAKAHASHI S, ANADA M, KINOSHITA T, et al. Prospective exploratory study of the relationship between radiation pneumonitis and TGF-β1 in exhaled breath condensate[J]. In Vivo, 2022, 36(3): 1485-1490. doi: 10.21873/invivo.12855
|
| [19] |
LV Q, WANG J J, XU C Q, et al. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways[J]. Mol Med, 2020, 26(1): 49. doi: 10.1186/s10020-020-00173-3
|
| [20] |
YANG M M, FAN Q, HEI T K, et al. Single-cell transcriptome analysis of radiation pneumonitis mice[J]. Antioxidants, 2022, 11(8): 1457. doi: 10.3390/antiox11081457
|
| [21] |
LI N, LUO P, LI C Y, et al. Analysis of related factors of radiation pneumonia caused by precise radiotherapy of esophageal cancer based on random forest algorithm[J]. Math Biosci Eng, 2021, 18(4): 4477-4490. doi: 10.3934/mbe.2021227
|
| [22] |
COOMES E A, HAGHBAYAN H. Interleukin-6 in Covid-19: a systematic review and meta-analysis[J]. Rev Med Virol, 2020, 30(6): 1-9.
|
| [23] |
DELLA-TORRE E, CAMPOCHIARO C, CAVALLI G, et al. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study[J]. Ann Rheum Dis, 2020, 79(10): 1277-1285. doi: 10.1136/annrheumdis-2020-218122
|
| [24] |
ZHANG J Y, WANG J X, GONG Y W, et al. Interleukin-6 and granulocyte colony-stimulating factor as predictors of the prognosis of influenza-associated pneumonia[J]. BMC Infect Dis, 2022, 22(1): 343. doi: 10.1186/s12879-022-07321-6
|
| [25] |
CHEN W, ZHONG K, GUAN Y, et al. Evaluation of the significance of interleukin-6 in the diagnosis of postoperative pneumonia: a prospective study[J]. BMC Cardiovasc Disord, 2022, 22(1): 306. doi: 10.1186/s12872-022-02744-0
|
| [26] |
XIE M, CHEN Y T, ZHANG H, et al. Diagnostic value of procalcitonin and interleukin-6 on early postoperative pneumonia after adult cardiac surgery: a prospective observational study[J]. Heart Surg Forum, 2022, 25(1): E020-E029.
|
| [27] |
NALBAN N, SANGARAJU R, ALAVALA S, et al. Arbutin attenuates isoproterenol-induced cardiac hypertrophy by inhibiting TLR-4/NF-κB pathway in mice[J]. Cardiovasc Toxicol, 2020, 20(3): 235-248. doi: 10.1007/s12012-019-09548-3
|
| [28] |
ZHAO D D, ZHANG X Z, FENG Y, et al. Taurine alleviates LPS-induced acute lung injury by suppressing TLR-4/NF-κB pathway[J]. Adv Exp Med Biol, 2022, 1370: 63-72.
|
| [29] |
李其耕, 邓永然, 欧雪, 等. NF-κB p65、IκBα、IL-1β mRNA在大鼠放射性肺损伤过程中的变化及意义[J]. 广西医科大学学报, 2018, 35(4): 459-463. https://www.cnki.com.cn/Article/CJFDTOTAL-GXYD201804011.htm
|
| [30] |
李超, 宋伟, 彭冰, 等. 养阴清热化瘀方对急性放射性肺炎大鼠TLR-4/NF-κB信号通路的影响[J]. 陕西中医, 2020, 41(7): 864-867. doi: 10.3969/j.issn.1000-7369.2020.07.007
|
| [31] |
DORNELES G P, TEIXEIRA P C, PERES A, et al. Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients[J]. J Mol Med, 2023, 101(1/2): 183-195.
|
| [32] |
汪盛, 王彩莲. 放射性肺炎临床相关预测因素的研究进展[J]. 中华放射肿瘤学杂志, 2021, 30(3): 305-310. doi: 10.3760/cma.j.cn113030-20200604-00292
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: